Liraglutide 3.0 emg efficacy and safety by baseline BMI in the SCALE Diabetes trial: post-hoc analysis

被引：0
|
作者：
Hemmingsson, J. Udden [1 ]
Rosenstock, J. [2 ]
Davies, M. [3 ]
Bays, H. [4 ]
Cancino, A. -P. [5 ]
Skjoth, T. V. [5 ]
Aroda, V. [6 ]
机构：
[1] Capio St Gorans Hosp, Stockholm, Sweden
[2] Diabet & Endocrine Ctr, Dallas, TX USA
[3] Univ Leicester, Leicester LE1 7RH, Leics, England
[4] L MARC Res Ctr, Louisville, KY USA
[5] Novo Nordisk, Soborg, Denmark
[6] MedStar Hlth Res Inst, Hyattsville, MD USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
646
引用
收藏
页码：S311 / S311
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Apixaban Versus Enoxaparin/Warfarin in Patients with Extremes of Body Weight: Post-Hoc Analysis of the AMPLIFY Trial
    Lee, Theodore
    Pan, Sharon
    Byon, Wonkyung
    Ilyas, Bushra S.
    BLOOD, 2019, 134
  • [22] EFFICACY AND SAFETY PROFILE OF IVABRADINE IN HEART FAILURE DUE TO CHAGAS' HEART DISEASE: A POST-HOC ANALYSIS OF THE SHIFT TRIAL
    Bocchi, Edimar Alcides
    Guimaraes, Guilherme
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 922 - 922
  • [23] Impact of ablation status on the efficacy and safety of dronedarone in patients with atrial fibrillation/flutter: a post-hoc analysis of the ATHENA trial
    Vamos, M.
    Calkins, H.
    Kowey, P. R.
    Torp-Pederson, C. T.
    Genti, V. Corp Dit
    Wieloch, M.
    Koren, A.
    Hohnloser, S. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 627 - 627
  • [24] Hepatic safety of ambrisentan alone and in combination with tadalafil: a post-hoc analysis of the AMBITION trial
    Patel, Krishna R.
    Blair, Christiana J.
    Tislow, James D.
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [25] Efficacy and safety of liraglutide 3.0 mg for weight management in overweight/obese adults: the SCALE obesity and prediabetes trial
    Fujioka, K.
    Wilding, J. P. H.
    Astrup, A.
    Greenway, F.
    Halpern, A.
    Krempf, M.
    Lau, D. C. W.
    le Roux, C.
    Violante Ortiz, R.
    Jensen, C. B.
    Lillleore, S. K.
    Pi-Sunyer, X.
    DIABETOLOGIA, 2014, 57 : S368 - S369
  • [26] Post-hoc analysis of ACCORD-BP trial
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11): : 850 - 850
  • [27] Efficacy of risankizumab versus ustekinumab by baseline Crohn's Disease location: post-hoc analysis of the SEQUENCE head-to-head trial
    Peyrin-Biroulet, L.
    Colombel, J. F.
    D'Haens, G.
    Dubinsky, M.
    Cao, Q.
    Kligys, K.
    Garrison, A.
    Huang, X.
    Neimark, E.
    Anschutz, T.
    Crowley, J.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I104 - I105
  • [28] Efficacy and safety of vedolizumab and adalimumab in Asian adults with moderately to severely active ulcerative colitis: Post-hoc analysis of the VARSITY trial
    Kim, J. S.
    Leung, W. K.
    Wu, D. C.
    Lindner, D.
    Fadeeva, O.
    Demuth, D.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S431 - S431
  • [29] Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
    Garvey, W. Timothy
    Birkenfeld, Andreas L.
    Dicker, Dror
    Mingrone, Geltrude
    Pedersen, Sue D.
    Satylganova, Altynai
    Skovgaard, Dorthe
    Sugimoto, Danny
    Jensen, Camilla
    Mosenzon, Ofri
    DIABETES CARE, 2020, 43 (05) : 1085 - 1093
  • [30] Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies
    Nyirjesy, P.
    Sobel, J. D.
    Degenhardt, T.
    Weclaw, C.
    Person, K.
    Mcgaurn, S.
    Brand, S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (02) : S784 - S784
12345